His research expertise lies in the design, development, and characterization of advanced drug delivery platforms, particularly polymeric nanoparticles and lipid–polymeric hybrid systems for targeted and controlled release applications. His work integrates pharmaceutical nanotechnology with pharmacokinetics, analytical method development (LC-MS, HPLC), and system validation to optimize therapeutic performance. He has also contributed significantly to emerging areas such as microneedle-based delivery systems, hydrogel-based formulations, wound healing applications, and ex vivo and in vivo evaluation models.Recognized for his scientific contributions, Dr. Mahmood has been listed among the world’s top 2% scientists (Stanford University ranking). His research continues to advance innovative pharmaceutical technologies with a focus on improving therapeutic efficacy, targeted delivery, and clinical translation.